Ara
Toplam kayıt 5, listelenen: 1-5
Geographical similarity and differences in the burden and genetic predisposition of NAFLD
(Wiley, 2022)
NAFLD has become a major public health problem for more than 2 decades with a growing prevalence in parallel with the epidemic of obesity and type 2 diabetes (T2D). The disease burden of NAFLD differs across geographical ...
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
(Sage Publications, 2022)
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the most common chronic liver disease worldwide – with an estimated global prevalence of 37%. Different from nonalcoholic fatty liver disease (NAFLD), which ...
Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply
(Wiley, 2023)
We appreciate the editorial comments by Drs. Sun and Fan about our study assessing the associations of patient-reported outcomes (PROs) and non-invasive tests (NITs) in patients with non-alcoholic fatty liver disease (NAFLD) ...
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
(SpringerNature, 2023)
Recompensation has gained increasing attention in the feld of cirrhosis,
particularly in chronic liver disease with a defnite aetiology. The current
global prevalence of obesity and nonalcoholic fatty liver disease
(NAFLD) ...
A multi-society Delphi consensus statement on new fatty liver disease nomenclatureA multisociety Delphi consensus statement on new fatty liver disease nomenclature
(Elsevier, 2023)
The principal limitations of the terms nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. ...